StockData
TherapeuticsMD, Inc. logo

TherapeuticsMD, Inc. (TXMD) stock

TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3029% below fair value
$1.81−0.10 (-5.24%)

Close on Nov 18, 2026Market cap $20.95MP/E –Yield –

TherapeuticsMD gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

TherapeuticsMD's gross profit for the twelve months ending Dec 31, 2023 was $1.30M, down 98.1% year over year. For fiscal 2023 it was $1.30M, down 98.1% from the year before. Over ten years it grew -15.3% a year on average. The highest annual figure on record is $68.57M in fiscal 2022.

Annual gross profit

PeriodPeriod endValueChange
FY2023Dec 31, 2023$1.30M-98.1%
FY2022Dec 31, 2022$68.57M+5755.3%
FY2021Dec 31, 2021$1.17M-97.6%
FY2020Dec 31, 2020$48.90M+12.9%
FY2019Dec 31, 2019$43.31M+224.1%
FY2018Dec 31, 2018$13.36M-5.5%
FY2017Dec 31, 2017$14.14M-6.8%
FY2016Dec 31, 2016$15.17M-3.0%
FY2015Dec 31, 2015$15.64M+37.7%
FY2014Dec 31, 2014$11.35M+66.6%
FY2013Dec 31, 2013$6.82M+176.0%
FY2012Dec 31, 2012$2.47M+116.5%
FY2011Dec 31, 2011$1.14M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$502.00K-99.3%
Q3 FY2023Sep 30, 2023-$53.00K–
Q2 FY2023Jun 30, 2023$437.00K–
Q1 FY2023Mar 31, 2023$416.00K-97.1%
Q4 FY2022Dec 31, 2022$68.57M+391.8%
Q3 FY2022Sep 30, 2022$0-100.0%
Q2 FY2022Jun 30, 2022$0-100.0%
Q1 FY2022Mar 31, 2022$14.47M-4.7%
Q4 FY2021Dec 31, 2021$13.94M-18.0%
Q3 FY2021Sep 30, 2021$20.12M+25.3%
Q2 FY2021Jun 30, 2021$18.87M+199.5%
Q1 FY2021Mar 31, 2021$15.18M+59.2%
Q4 FY2020Dec 31, 2020$17.00M+30.5%
Q3 FY2020Sep 30, 2020$16.06M-27.9%
Q2 FY2020Jun 30, 2020$6.30M+30.5%
Q1 FY2020Mar 31, 2020$9.54M+199.5%
Q4 FY2019Dec 31, 2019$13.02M+214.6%
Q3 FY2019Sep 30, 2019$22.28M+702.7%
Q2 FY2019Jun 30, 2019$4.83M+46.0%
Q1 FY2019Mar 31, 2019$3.18M+1.4%
Q4 FY2018Dec 31, 2018$4.14M+17.3%
Q3 FY2018Sep 30, 2018$2.78M-25.3%
Q2 FY2018Jun 30, 2018$3.31M-7.3%
Q1 FY2018Mar 31, 2018$3.14M-5.6%
Q4 FY2017Dec 31, 2017$3.53M-6.6%
Q3 FY2017Sep 30, 2017$3.72M-13.5%
Q2 FY2017Jun 30, 2017$3.57M–
Q1 FY2017Mar 31, 2017$3.33M–
Q4 FY2016Dec 31, 2016$3.78M–
Q3 FY2016Sep 30, 2016$4.30M–

More TherapeuticsMD figures

See a number that looks wrong?